The CRC-specific biomarker CD110 also has an essential role in lysine catabolism and activates the Wnt signaling pathway by upregulating acetylated low-density lipoprotein receptor related-protein 6 (LRP6) and glutathione (132, 133). This evidence concerns the gene LRP6 and colorectal carcinoma.